] . The contribution of qualitative research within the PRECISE study in sub-Saharan Africa. Reproductive Health. 2020;17(S1). 
(507.25 KB)
(507.25 KB). A core outcome set for pre‐eclampsia research: An international consensus development study. BJOG: An International Journal of Obstetrics & Gynaecology. 2020;. (257.34 KB)
(257.34 KB). Harnessing the PRECISE network as a platform to strengthen global capacity for maternal and child health research in sub-Saharan Africa. Reproductive Health. 2020;17(S1). (1.12 MB)
(1.12 MB). Investigating placental disorders of pregnancy in sub-Saharan Africa: addressing the gap in a neglected area of research. 2020;17(1):53. (402.49 KB)
(402.49 KB). The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network’s first protocol: deep phenotyping in three sub-Saharan African countries. Reproductive Health. 2020;17(S1). (1.89 MB)
(1.89 MB). The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) database: open-access data collection in maternal and newborn health. Reproductive Health. 2020;17(S1). (1.21 MB)
(1.21 MB). PRECISE pregnancy cohort: challenges and strategies in setting up a biorepository in sub-Saharan Africa. Reproductive Health. 2020;17(S1). (633.9 KB)
(633.9 KB). COLLECT, a collaborative database for pregnancy and placental research studies worldwide. BJOG. 2019;126(1):8-10. (127.54 KB)
(127.54 KB). How accurate are modelled birth and pregnancy estimates? Comparison of four models using high resolution maternal health census data in southern MozambiqueBackgroundMethodsResultsConclusion. BMJ Global Health [Internet]. 2019;4(Suppl 5):e000894. http://gh.bmj.com/lookup/doi/10.1136/bmjgh-2018-000894https://syndication.highwire.org/content/doi/10.1136/bmjgh-2018-000894 (1.77 MB)
(1.77 MB). The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16(4):e1002783. (864.32 KB)
(864.32 KB). Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. The Lancet. 2019;. (235.23 KB)
(235.23 KB). Place-specific factors associated with adverse maternal and perinatal outcomes in Southern Mozambique: a retrospective cohort study. BMJ Open. 2019;9(2):e024042. (2.94 MB)
(2.94 MB). Policy review on the management of pre-eclampsia and eclampsia by community health workers in Mozambique. Human Resources for Health [Internet]. 2019;17(1). https://human-resources-health.biomedcentral.com/articles/10.1186/s12960-019-0353-9http://link.springer.com/content/pdf/10.1186/s12960-019-0353-9.pdf (687.16 KB)
(687.16 KB). PRE-EMPT Selected scientific abstracts, 2011-2019. 2019;:1-81. (21.32 MB)
(21.32 MB). Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10169):330-339. (10.3 MB)
(10.3 MB). Protocol 11PRT/4028: Long term calcium supplementation in women at high risk of pre-eclampsia: a randomised, placebo-controlled trial. The Lancet [Internet]. 2019;. https://www.thelancet.com/protocol-reviews/11PRT-4028
. Protocol 13PRT/9313:The Community Level Interventions for Pre-eclampsia (CLIP) Trials: four prospective cluster randomised controlled trials comparing a package of interventions directed towards improving maternal and perinatal outcomes related to pre-ecl [Internet]. 2019 . https://clinicaltrials.gov/ct2/show/study/NCT01911494?term=01911494&rank=1
. Self-reported maternal morbidity: Results from the community level interventions for pre-eclampsia (CLIP) baseline survey in Sindh, Pakistan. Pregnancy Hypertension. 2019;17:113 - 120. (1.03 MB)
(1.03 MB). Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia. Pregnancy Hypertens. 2019;15:42-50. (887.01 KB)
(887.01 KB). Are women with history of pre-eclampsia starting a new pregnancy in good nutritional status in South Africa and Zimbabwe?. BMC Pregnancy Childbirth. 2018;18(1):236. (712.34 KB)
(712.34 KB). Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665. (237.99 KB)
(237.99 KB). Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India. Reproductive Health [Internet]. 2018;15(S1). https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-018-0531-6http://link.springer.com/content/pdf/10.1186/s12978-018-0531-6.pdf (460.75 KB)
(460.75 KB). CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial. Pregnancy Hypertens. 2018;14:15-22. (1011.52 KB)
(1011.52 KB). A comparison of maternal and newborn health services costs in Sindh Pakistan. PLoS One. 2018;13(12):e0208299. (645.08 KB)
(645.08 KB). The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings. Reprod Health. 2018;15(1):5. (394.63 KB)
(394.63 KB). Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model. Crit Care. 2018;22(1):278. (961.71 KB)
(961.71 KB). Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique. Pregnancy Hypertens. 2018;11:26-31. (374.54 KB)
(374.54 KB). Economic evaluation of the Community-Level Interventions for Pre-eclampsia (CLIP) in Sindh, Pakistan. In 2018. (2.53 MB)
(2.53 MB). Endoglin pathway genetic variation in preeclampsia: A validation study in Norwegian and Latina cohorts. Pregnancy Hypertens. 2018;12:144-149. (258.96 KB)
(258.96 KB). The feasibility of task-sharing the identification, emergency treatment, and referral for women with pre-eclampsia by community health workers in India. Reprod Health. 2018;15(Suppl 1):101.
. Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique. PLoS One. 2018;13(2):e0184249. (3.25 MB)
(3.25 MB). Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Hypertension. 2018;71(6):1170-1177. (303.94 KB)
(303.94 KB). MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada. Implement Sci. 2018;13(1):8. (1.89 MB)
(1.89 MB). Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review. Pregnancy Hypertens. 2018;11:115-123. (501.41 KB)
(501.41 KB). Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia. Sci Rep. 2018;8(1):6342. (3.16 MB)
(3.16 MB). Advocacy is essential to supporting women with pre-eclampsia. Obstet Med. 2017;10(1):33-35. (85.27 KB)
(85.27 KB). Availability of COLLECT, a database for pregnancy and placental research studies worldwide. Placenta. 2017;57:223-224. (141.67 KB)
(141.67 KB). Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev. 2017;9:CD011192. (116.05 KB)
(116.05 KB). Community perceptions of the hypertensive disorders of pregnancy. In 2017. (2.63 MB)
(2.63 MB). The cytotrophoblastic shell and complications of pregnancy. Placenta. 2017;60:134-139. (1.81 MB)
(1.81 MB). Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study. Diagnostic and Prognostic Research. 2017;1(1). (428.07 KB)
(428.07 KB). Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique. Hypertension. 2017;69(3):469-474. (378.99 KB)
(378.99 KB). Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta. 2017;60:119-129. (1.43 MB)
(1.43 MB). External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017;69(4):705-711. (149.83 KB)
(149.83 KB). Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis. Int J Epidemiol. 2017;46(2):632-642. (530.75 KB)
(530.75 KB). THE fullPIERS RISK PREDICTION MODEL FOR WOMEN WITH PRE-ECLAMPSIA: EXTERNAL VALIDATION, RECALIBRATION AND ADDED VALUE OF A NOVEL BIOMARKER (PLACENTAL GROWTH FACTOR). In 2017. (2.49 MB)
(2.49 MB). Genes, epigenetics and miRNA regulation in the placenta. Placenta. 2017;52:127-133. (495.08 KB)
(495.08 KB). Geographic information system for improving maternal and newborn health: recommendations for policy and programs. BMC Pregnancy Childbirth. 2017;17(1):26. (3.02 MB)
(3.02 MB). Global Pregnancy Collaboration symposium on placental health: Summary and recommendations. Placenta. 2017;52:116-121. (440.44 KB)
(440.44 KB). Global Pregnancy Collaboration symposium: Prepregnancy and very early pregnancy antecedents of adverse pregnancy outcomes: Overview and recommendations. Placenta. 2017;60:103-109. (216.45 KB)
(216.45 KB)